Translational sciences approach to RSV vaccine development.

Expert review of vaccines

Volumn 12, Issue 9, 2013, Pages 1047-1060

  Kurzweil, Vanessa ^a   Tang, Roderick ^b   Galinski, Mark ^b   Wang, Kathy ^b   Zuo, Fengrong ^b   Cherukuri, Anu ^b   Gasser, Robert A ^b   Malkin, Elissa ^b   Sifakis, Frangiscos ^b   Mendel, Dirk B ^b   Esser, Mark T ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; MONOCLONAL ANTIBODY; PALIVIZUMAB; RESPIRATORY SYNCYTIAL VIRUS VACCINE;

DRUG DEVELOPMENT; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; ISOLATION AND PURIFICATION; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TRENDS;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIVIRAL AGENTS; DRUG DISCOVERY; HUMANS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 84891160602     PISSN: None     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2013.824706     Document Type: Review

References (0)